Source: British Journal of Haematology. Unidade: FMRP
Subjects: LEUCEMIA, PROTEÍNAS PROTO-ONCOGÊNICAS
ABNT
LANGE, A. P. et al. The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia. [Carta]. British Journal of Haematology. West Sussex: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1111/bjh.14490. Acesso em: 06 nov. 2024. , 2018APA
Lange, A. P., Lima, A. S., Lucena-Araújo, A. R., Jácomo, R. H., Melo, R. A., Bittencourt, R. I., et al. (2018). The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia. [Carta]. British Journal of Haematology. West Sussex: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1111/bjh.14490NLM
Lange AP, Lima AS, Lucena-Araújo AR, Jácomo RH, Melo RA, Bittencourt RI, Pasquini R, Pagnano K, Fagundes EM, Rego EM. The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia. [Carta] [Internet]. British Journal of Haematology. 2018 ; 180( 6): 915-918.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1111/bjh.14490Vancouver
Lange AP, Lima AS, Lucena-Araújo AR, Jácomo RH, Melo RA, Bittencourt RI, Pasquini R, Pagnano K, Fagundes EM, Rego EM. The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia. [Carta] [Internet]. British Journal of Haematology. 2018 ; 180( 6): 915-918.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1111/bjh.14490